Jennifer Strickland, Physician Assistant

Jennifer Strickland, MS, PA-C, is a vital clinician-researcher in the Division of Infectious Diseases at CHOC, bridging the gap between bedside care and academic advancement. Her research contributions have assisted the division with studying various topics including on the safety and efficacy of pediatric therapeutics, including Remdesivir for SARS-CoV-2 and the pharmacokinetics of Oxacillin in neonates. Furthermore, she has been instrumental in evaluating diagnostic tools like procalcitonin to better differentiate bacterial infections, sharing these insights at major international forums such as the European Society for Paediatric Infectious Diseases (ESPID).

Location

CHOC Specialists, Infectious Diseases
1201 W. La Veta Ave.
Orange, CA 92868
phone: 714-509-8403
fax: 714-509-4014

Education

• Medical School
  Western University of Health Sciences, Pomona, CA

Division Duties

• Clinical care, physician assistant, Pediatric Infectious Diseases – CHOC
• Research assistant, Infectious Diseases clinical research

Recent Research Presentations

Nieves DJ, Tran MT, Lusk JG, Singh J, Ashouri N, Adler-Shohet F, Marano R, Osborne SA, Strickland J, and Arrieta A. Safety and tolerability of Remdesivir for severe infection and prevention of disease in pediatric patients with SARS-CoV-2 infection. Pediatric Academic Societies. May 2024. Toronto, Canada. May 5, 2024.

Strickland J, Osborne S, Nugent D, Hoang J, Enriquez C, Imfeld K, Arrieta A. Procalcitonin plasma and urine levels and urine/plasma procalcitonin ratio do not help discriminate urinary tract infection from other serious bacterial infections. Poster presentation at the 43rd  Annual meeting of European Society for Paediatric Infectious Diseases (ESPID). May 26-30, 2025. Bucharest, Romania

Lee A. Tran T, Liu C, Capparelli E, Phal S, Enriquez C, Osborne S, Strickland J, Cohen-Wolkowiez M, Hornik C.D., Ashouri N. Nieves D, Shaw A, Singh J, Arrieta A.  Population pharmacokinetics and safety of continuous oxacillin in preterm and term neoanates and infants. Oral presentation at the 43rd Annual meeting of European Society for Paediatric Infectious Diseases (ESPID). May 26-30, 2025. Bucharest, Romania

Arrieta A, Osborne S, Strickland J, Grant L, Hulten K, Nieves D, Miller A, Bender C, Sommer L, Cane A, Arguedas A, Tort M, Gessner B. Urinary antigen and nasopharyngeal PCR for serotype detection among children ages 3-<72 months with upper respiratory infection community acquired pneumonia and healthy control. Interim report. Poster presentation at the 43rd Annual meeting of European Society for Paediatric Infectious Diseases (ESPID). May 26-30, 2025. Bucharest, Romania

Publications

Nieves, Delma J., M. Tuan Tran, Jasjit Singh, Negar Ashouri, Tricia Morphew, Jennifer G. Lusk, Felice C. Adler-Shohet, Rachel Marano, Stephanie Osborne, Jennifer Strickland, and Antonio C. Arrieta. 2025. “Remdesivir Use in Pediatric Patients with Acute SARS-CoV-2 Infection Is Safe and Well Tolerated” Children 12, no. 3: 331. https://doi.org/10.3390/children12030331

Embolization of a third ventricular choroid plexus papilloma: illustrative case. J Neurosurg Case Lessons. 2022 Jan 31; 3(5): CASE21516. Jordan C. Xu, MD, Shuichi Suzuki, MD, PhD, Jennifer Chrislip, PA-C, Ali Nael, MD, and William G. Loudon, MD, PhD. PMC9379751.